HSD10 Efficiency of the Cervical Cancer Program on the Budget Execution Processes during COVID 19 Pandemic Years 2020 - 2021 in Peru

The study aims to determine the influence of efficiency cervical cancer program on budget execution during COVID-19 pandemic years 2020- 2021. Estimating screened women and using a micro-costing analysis estimate cost treating precancerous lesions in non-pandemic scenario 2020 -2021. Finally, estimation for led by Ministry Health scenarios. was through two scenarios determined, After that, it determined number non-screened women. next step low-grade squamous intraepithelial lesion (LSIL), high-grade (HSIL), at different stages. Therefore, this information is necessary Peruvian provide healthcare services patients who did not get would be spent USD 33,547,185 37,428,997 2021, respectively. Conversely, scenario, 9,934,440 23,762,073 must 68.7% budget, but only had been 20.3%. Moreover, 46.7% when should 73.6% total budget. 39,496,476 27,114,114 were executed A 66,610,590 non-executed needs reallocated following access screening treatment.